Ascendis Pharma
ASND
ASND
166 hedge funds and large institutions have $9.25B invested in Ascendis Pharma in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 48 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 170 → 166 (-4)
13% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 31
31% less call options, than puts
Call options by funds: $22.7M | Put options by funds: $33.1M
Holders
166
Holding in Top 10
12
Calls
$22.7M
Puts
$33.1M
Top Buyers
| 1 | +$216M | |
| 2 | +$160M | |
| 3 | +$92.7M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$81.4M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$53.4M |
Top Sellers
| 1 | -$122M | |
| 2 | -$58.9M | |
| 3 | -$49.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$44.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$35.9M |